Oligosymptomatic long-term carriers of SARS-CoV-2 display impaired innate resistance but increased high-affinity anti-spike antibodies

SARS-CoV-2 长期携带者(无症状)表现出先天抵抗力受损,但高亲和力抗刺突蛋白抗体水平升高。

阅读:3
作者:Elena Montes-Cobos ,Victoria C Bastos ,Clarice Monteiro ,João C R de Freitas ,Heiny D P Fernandes ,Clarice S Constancio ,Danielle A S Rodrigues ,Andreza M D S Gama ,Vinicius M Vidal ,Leticia S Alves ,Laura Zalcberg-Renault ,Guilherme S de Lira ,Victor A Ota ,Carolina Caloba ,Luciana Conde ,Isabela C Leitão ,Amilcar Tanuri ,Orlando D C Ferreira ,Renata M Pereira ,André M Vale ,Terezinha M Castiñeiras ,Dominique Kaiserlian ,Juliana Echevarria-Lima ,Marcelo T Bozza

Abstract

The vast spectrum of clinical features of COVID-19 keeps challenging scientists and clinicians. Low resistance to infection might result in long-term viral persistence, but the underlying mechanisms remain unclear. Here, we studied the immune response of immunocompetent COVID-19 patients with prolonged SARS-CoV-2 infection by immunophenotyping, cytokine and serological analysis. Despite viral loads and symptoms comparable to regular mildly symptomatic patients, long-term carriers displayed weaker systemic IFN-I responses and fewer circulating pDCs and NK cells at disease onset. Type 1 cytokines remained low, while type-3 cytokines were in turn enhanced. Of interest, we observed no defects in antigen-specific cytotoxic T cell responses, and circulating antibodies displayed higher affinity against different variants of SARS-CoV-2 Spike protein in these patients. The identification of distinct immune responses in long-term carriers adds up to our understanding of essential host protective mechanisms to ensure tissue damage control despite prolonged viral infection.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。